Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants.

Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants.

BACKGROUND: The high cost of pneumococcal conjugate vaccine (PCV) and local epidemiological factors contributed to evaluating different PCV dosing-schedules. This study evaluated the immunogenicity of seven-valent PCV (PCV7) administered at 6-weeks; 14-weeks and 9-months of age. METHODS: 250 healthy...

Full description

Bibliographic Details
Main Authors: Stephanie A Jones, Michelle Groome, Anthonet Koen, Nadia Van Niekerk, Poonam Sewraj, Locadiah Kuwanda, Alane Izu, Peter V Adrian, Shabir A Madhi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3755982?pdf=render

Internet

http://europepmc.org/articles/PMC3755982?pdf=render

Similar Items